Kidneys Home > Simulect Medication Information

If you have a kidney transplant, your healthcare provider may prescribe Simulect® (basiliximab) to help prevent the rejection of your new kidney. This medicine works by binding to certain white blood cells to prevent them from attacking the newly transplanted kidney.
Simulect comes as a powder that is dissolved in fluid and given as an intravenous (IV) injection or infusion. It is administered by a healthcare provider in a healthcare setting. The first dose is given within two hours after transplant surgery, and the second dose is given four days later.
Before starting treatment with Simulect, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to use this medicine if you have certain allergies, cancer, or a history of transplant rejection.
Although most people tolerate Simulect well, side effects can occur. Some of the common reactions reported with this drug include nausea, headaches, and constipation.
(Click Simulect for more information on this medication, including detailed dosing guidelines, other safety warnings to be aware of, and what to do if you are pregnant or breastfeeding.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.